Shenzhen Chipscreen Biosciences Co (688321) — Working Capital to Net Assets Ratio
Shenzhen Chipscreen Biosciences Co (688321) has a Working Capital to Net Assets ratio of 37.6% as of September 2025. Working capital of CN¥622.49 Million (current assets of CN¥1.34 Billion minus current liabilities of CN¥716.04 Million) is measured against net assets of CN¥1.66 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Shenzhen Chipscreen Biosciences Co balance sheet independence to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Shenzhen Chipscreen Biosciences Co Working Capital to Net Assets (2016–2024)
This chart shows how Shenzhen Chipscreen Biosciences Co's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 37.6%, reflecting working capital of CN¥622.49 Million against net assets of CN¥1.66 Billion CNY. Check 688321 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Shenzhen Chipscreen Biosciences Co (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Shenzhen Chipscreen Biosciences Co from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Shenzhen Chipscreen Biosciences Co (688321) market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 40.0% | CN¥632.16 Million | CN¥1.58 Billion | CN¥1.08 Billion | CN¥451.31 Million | ▼ -3.3 pp |
| 2023 | 43.2% | CN¥739.28 Million | CN¥1.71 Billion | CN¥1.13 Billion | CN¥390.81 Million | ▲ +2.4 pp |
| 2022 | 40.8% | CN¥643.59 Million | CN¥1.58 Billion | CN¥1.18 Billion | CN¥540.54 Million | ▲ +16.5 pp |
| 2021 | 24.3% | CN¥344.98 Million | CN¥1.42 Billion | CN¥638.82 Million | CN¥293.84 Million | ▼ -17.3 pp |
| 2020 | 41.6% | CN¥622.17 Million | CN¥1.49 Billion | CN¥769.06 Million | CN¥146.89 Million | ▼ -23.0 pp |
| 2019 | 64.6% | CN¥934.92 Million | CN¥1.45 Billion | CN¥1.07 Billion | CN¥137.31 Million | ▲ +32.8 pp |
| 2018 | 31.9% | CN¥151.93 Million | CN¥476.90 Million | CN¥233.47 Million | CN¥81.53 Million | ▼ -20.1 pp |
| 2017 | 52.0% | CN¥234.10 Million | CN¥450.55 Million | CN¥310.82 Million | CN¥76.72 Million | ▼ -1.7 pp |
| 2016 | 53.7% | CN¥114.49 Million | CN¥213.40 Million | CN¥226.05 Million | CN¥111.56 Million | — |